Trials / Conditions / Juvenile Dermatomyositis (JDM)
Juvenile Dermatomyositis (JDM)
4 registered clinical trials studyying Juvenile Dermatomyositis (JDM) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) NCT07111065 | National Institute of Environmental Health Sciences (NIEHS) | Phase 2 |
| Recruiting | Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases NCT07184450 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Terminated | COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders NCT05000216 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Approved For Marketing | Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes NCT01724580 | Eli Lilly and Company | — |